| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |